Speed to result

The Genedrive® molecular diagnostic system has been developed as an affordable next generation genotyping and sequence analysis device, providing rapid detection in approximately 45-75 minutes depending on the test.

The first test developed on the Genedrive® is MTB/RIF which allows small/medium laboratories to test for TB thus speeding up diagnosis and treatment and improving prognosis.

Genedrive is a trading name of Epistem Ltd
Copyright 2014-16 Epistem Ltd, a division of genedrive plc